US-based contract research organisation (CRO) Kendle has put in place a new global biostatistics infrastructure.

The centralised SAS-based platform will “significantly enhance the analysis and delivery of quality clinical data for customers”, Kendle says. It provides a virtual environment allowing for simultaneous access to, and analysis of, clinical trial data by the CRO’s Biostatistics and Scientific Programming teams from anywhere in the world.

That means significant time savings and even better data security, Kendle notes. “With this new environment, data will be processed at the server level much faster than ever before, greatly improving the productivity of our teams around the world and expediting the delivery of quality data to our customers,” commented Dr John Whitaker, vice president, biostatistics and statistical programming.

The centralised platform will also enable Kendle to leverage better its growing operations in India, along with other benefits such as improved network performance and simplification of testing, production and recovery environments, the CRO added.

Kendle recently announced it was setting up an operations centre within a Special Economic Zone (SEZ) in India’s Ahmedabad-Gandhinagar Knowledge Corridor. The new facility will handle clinical data management as well as medical writing, pharmacovigilance/safety, biostatistics/programming and other services.